Faced with competition, some pharmaceutical companies are cutting deals with insurance companies to favor their brand-name products over cheaper generics, reports Pro Publica and The New York Times. Insurers pay less, but sometimes consumers pay more. Out of public view, corporations are cutting deals that give consumers little choice but to buy brand-name drugs — and sometimes pay more at the pharmacy counter than they would for generics. The practice is not easy to track, and has been going on sporadically for years. But several clues suggest it is becoming more common.
How do companies value the injured body parts of their workers?
Injured workers are entitled to compensation for permanent disabilities under state workers’ comp laws. Pro Publica investigated how companies in Texas and elsewhere value the injured body parts of their workers and here’s what they found.
Corporations and Health Watch 